Infectivity-associated plasmids were identified in Borrelia burgdorferi B31 by using PCR to detect each of the plasmids in a panel of 19 clonal isolates. The clones exhibited high-, low-, and intermediate-infectivity phenotypes based on their frequency of isolation from needle-inoculated C3H͞HeN mice. Presence or absence of 21 of the 22 plasmids was determined in each of the clones by using PCR primers specific for regions unique to each plasmid, as identified in the recently available genome sequence. Southern blot hybridization results were used to confirm the PCR results in some cases. Plasmid lp25 exhibited a direct correlation with infectivity in that it was consistently present in all clones of high or intermediate infectivity and was absent in all low-infectivity clones. lp28 -1, containing the vmp-like sequence locus, also correlated with infectivity; all clones that lacked lp28 -1 but contained lp25 had an intermediate infectivity phenotype, in which infection was primarily restricted to the joints. Plasmids cp9, cp32-3, lp21, lp28 -2, lp28 -4, and lp56 apparently are not required for infection in this model, because clones lacking these plasmids exhibited a high-infectivity phenotype. Plasmids cp26, cp32-1, cp32-2 and͞or cp32-7, cp32-4, cp32-6, cp32-8, cp32-9, lp17, lp28 -3, lp36, lp38, and lp54 were consistently present in all clones examined. On the basis of these results, lp25 and lp28 -1 appear to encode virulence factors important in the pathogenesis of B. burgdorferi B31.
B
orrelia burgdorferi strain B31 (Bb), one of a group of closely related spirochetes that cause Lyme disease (1) , has a genome consisting of a linear chromosome of 910,724 base pairs (2) and 21 linear and circular plasmids containing over 610,694 base pairs (plus unsequenced telomere regions) (3) . The chromosome contains 853 predicted genes, of which 500 (59%) have predicted functions based on amino acid sequence similarity with orthologous gene products (2) . The 535 putative gene products encoded by the B. burgdorferi plasmids are predominantly of unknown function and include many paralogous gene families (2, 3) . Comparison of the plasmid profiles of Lyme disease spirochetes, including B. burgdorferi, Borrelia afzelii, and Borrelia garinii, demonstrates that a high degree of heterogeneity and plasticity exists in terms of plasmid content (4) .
Considerable evidence indicates that Bb plasmids are important in pathogenesis. In vitro passage of Bb is associated with loss of plasmids (5) . Plasmid loss after 10-17 passages is also coupled with decreased infectivity in mice and changes in spirochetal protein expression (6) (7) (8) (9) . High-and low-infectivity phenotypes of Bb coexist in an uncloned population, but the proportion of high-infectivity phenotypes decreases with serial in vitro passage (10) . Plasmid profiles vary among certain Bb sensu lato strains (including Bb sensu stricto, B. garinii, and B. afzelii) as well as within high-and low-passaged cultures; this variance is associated with infectivity of Bb in mice (5, (9) (10) (11) (12) (13) .
Before the availability of the Bb genome sequence, methods such as pulsed-field agarose gel electrophoresis (PFGE), electron microscopy, two-dimensional agarose gel electrophoresis, and Southern blotting were used to identify Borrelia plasmids associated with infectivity in mammals. Schwan et al. (9) discovered a correlation between infectivity in white-footed mice and presence of the 7.6-kb circular and 22-kb linear plasmids by using agarose gel electrophoresis and electron microscopy to identify the plasmids. Xu et al. (12) found a relationship between infectivity in hamsters and presence of the 24.7-and 28.1-kb linear plasmids by using PFGE and two-dimensional agarose gel electrophoresis for plasmid detection. The infectivity of 10 Bb B31 clonal isolates and an equivalent number of Sh2-82 clones correlated with the presence of lp28 -1 by using PFGE and Southern blotting (13) . In this study, the Bb B31 genome sequence information in combination with PCR and Southern blot hybridization provided a comprehensive assessment of plasmid content and its correlation with infectivity in a panel of 19 Bb B31-derived clonal isolates.
Materials and Methods
Bacteria. Infectious Bb B31 were originally obtained from Alan Barbour (University of California at Irvine College of Medicine) and had undergone three in vitro passages. Clones were isolated by the subsurface agarose plating method described previously and thereby had undergone a total of five in vitro passages (10, 14) . The B31 clones (B31-5A1 through B31-5A19) were maintained as frozen stocks, as described previously (10) , and were subsequently subjected to a maximum of two additional in vitro passages in Barbour͞Stoenner͞Kelly (BSK) II medium (15) during this study.
potentially be amplified in one PCR reaction. The cp32-1 PCR primers, originally named ORFD-1 and ORFD-2, were designed by Casjens et al. (18) . cp32-2 and͞or cp32-7 were detected by using primers originally named E-311 and E-328, respectively, designed by Stevenson et al. (19) ; because both plasmids have identical orfC-orf3 loci, the primers could not differentiate between cp32-2 and cp32-7. Cp32-6 (CP6-1 and CP6-2), cp32-8 (CP8-1 and CP8-2), and cp32-9 (CP9-1 and CP9-2) were detected by using previously reported oligonucleotides (19) . All other primers were designed in this study. Two unique PCR target sites were identified in the plasmids lp25 and lp28-1, whereas single sites were determined for the other plasmids. Thus far, we have been unable to obtain plasmid-specific amplification for lp5; it therefore was not included in this study. Primer sequences were analyzed for potential false priming on the Institute for Genomic Research website (http:͞͞www.tigr.org͞tdb͞CMR͞gbb͞htmls͞SeqSearch.html) by using GRASTA, a modified form of the FASTA program (20) . The oligonucleotide primers selected for this study are published as supplemental data on the PNAS web site, www.pnas.org.
PCR Detection of Plasmids. PCR (total volume ϭ 50 l) was performed by using the Amresco Tbr polymerase kit according to the manufacturer's conditions (Euclid, OH). Two microliters of frozen stock cultures (in Barbour͞Stoenner͞Kelly II medium plus 15% glycerol) for each clone was used as template rather than purified plasmid DNA. PCR primers (Sigma-Genosys, The Woodlands, TX, and Integrated DNA Technologies, Coralville, IA) were used at a final concentration of 1.25 M. Reaction solutions were overlaid with 20 l of ChillOut wax (MJ Research, Cambridge, MA) and performed in an MJ Research Minicycler. An annealing temperature of 55°C and 35 cycles were used for most reactions. In cases where the T m of either primer was below 55°C, the annealing temperature was adjusted to the lowest primer T m minus 2°C. Ten-microliter samples of each reaction were electrophoresed in 1.5% agarose gels and visualized by ethidium bromide staining (21 (21) , denatured, and crosslinked to the membranes by using UV light. Probes from primary and secondary sites on plasmids lp25 and lp28-1 (see supplemental data) were amplified by using PCR as described above and purified by using the Wizard PCR Prep kit (Promega). The purified denatured DNA was labeled by using the Amersham Gene Images Random Prime Labeling and Detection System (Amersham Pharmacia Biotech). Southern blot hybridization and detection were performed according to the manufacturer's instructions. table and   2 goodnessof-fit test were used to test the null hypothesis, ''Infectivity is independent of presence of the plasmid.'' To eliminate bias that can occur in 2 goodness-of-fit testing when expected frequencies are less than 6 (the mean frequency for this data set was 4.75), the log-likelihood ratio was applied to the contingency table data and the G statistic calculated (22) .
Results
Infectivity Phenotypes of 19 Bb B31 Clones. A test of infectivity was used for Bb B31 clones 5A1 through 5A19, in which 10 5 spirochetes were injected s.c. into groups of three 6-week-old female C3H͞HeN mice. This high dose of organisms was used to permit clear differentiation of infectivity phenotypes (23) . Three infectivity phenotypes were identified among the clones (Table  1 ). In the high-infectivity phenotype, all tissue samples tested were culture positive; in the low-infectivity clones, all tissue 
samples tested were culture negative. Clones 5A2 and 5A8 were primarily culture negative, except for cultures of tibiotarsal joints, which were predominantly culture positive. These were designated as intermediate-infectivity clones. In other studies, it was determined that the intermediate-infectivity phenotype of B31 5A2 was retained after serial infection of mice; therefore this phenotype was not the result of the outgrowth of highinfectivity subpopulations within a low-infectivity background (J.-R. Zhang and S.J.N., unpublished data).
Plasmid Content of 19 Bb B31 Clones. Plasmid content of each of the 19 Bb B31 clones was determined before mouse inoculation. PCR primers were selected for specific detection of each plasmid in the Institute for Genomic Research Bb genome sequence database. Primer sequences, amplicon coordinates, and T m information are included in the supplemental data. PCR amplification resulted in clear differentiation of B31 clones that contained or lacked the corresponding plasmids, as exemplified by the amplicons shown in Fig. 1 . The interpretation of these results is presented in Table 2 . On the basis of the PCR data, plasmid lp25 was present in all high-and intermediate-infectivity clones but was absent in all lowinfectivity clones tested. PCR positivity for plasmid lp28 -1 was absent in all of the intermediate-infectivity clones and in some of the low-infectivity clones but was never absent in a highinfectivity clone. In addition, all clones that lacked lp28 -1 but contained lp25 expressed an intermediate-infectivity phenotype, in which infection was primarily restricted to the joints. Plasmids cp9, cp32-3, lp21, lp28 -2, lp28 -4, and lp56 were detected in some of the 19 clones; however, each was absent in at least one high-infectivity clone, indicating they are not required for infectivity in this model. Plasmids cp26, cp32-1, cp32-2,7 (see Table 2 ), cp32-4, cp32-6, cp32-8, cp32-9, lp17, lp28 -3, lp36, lp38, and lp54 were present in all clones examined. Therefore an association between these plasmids and infectivity could not be determined in this study. cp32-2 and cp32-7 are closely related, and the primer set used in this study for detection of these plasmids (19) could not differentiate between them. Amplification was consistently observed in each of the 19 B31 clones when this primer set was used, indicating that either one or both of these plasmids was consistently present. Sequences for cp32-5 were unavailable at the time of this study. Primers useful for the specific amplification of lp5 were not identified. The possibility existed that some of the negative PCR results were because of deletions or recombinations in the amplified region. To test this possibility, a second set of PCR primers was designed for amplification of lp25 and lp28-1 at sites distant from the initial amplification site (see supplemental data). In each of the 19 clones, the results obtained with the primary and secondary PCR reactions were identical (data not shown), supporting the interpretation that PCR positivity or negativity corresponded to the presence or absence of the targeted plasmid.
Southern Blot Hybridization. Southern blot analysis of plasmid DNA from Bb B31 clones 5A1 through 5A19 were performed by using probes of PCR-amplified primary and secondary unique regions from plasmids lp25 and lp28-1. Fig. 2 demonstrates that the Southern blot results for each plasmid agreed with the PCR results.
Statistical Analysis. A 2 ϫ 2 contingency table was used to test the null hypothesis, ''Infectivity is independent of presence of Present in all clones Not infectivity associated lp25 lp28-1 cp26 cp32-1 cp32-2,7 cp32-4 cp32-6 cp32-8 cp32-9 lp17 lp28-3 lp36 lp38 lp54 cp9 cp32-3 lp21 lp28-2 lp28-4 lp56
*As determined by PCR amplification (Fig. 1 ) and confirmed by Southern hybridization for lp25 and lp28-1 (Fig. 2) . † Infectivity phenotype determined by needle inoculation of C3H͞HeN mice (Table 1) . lp25
goodness-of-fit testing when expected frequencies are less than 6. Because the mean frequency for this data set was 4.75, the logarithm͞likelihood ratio was applied to the contingency table data and G statistic calculated as a second test of goodness of fit. The calculated G of 25.043 was greater than 2 0.05,1 of 3.841. Again, the null hypothesis was rejected, P Ͻ 0.001 (22) . Similar results were obtained by using the 2 test for lp28-1 ( 2 ϭ 70.4, 2 0.05,1 ϭ 3.841, P Ͻ 0.001). However, the association of lp28-1 with infectivity was not statistically significant by using the G-statistic analysis (0.10 Ͻ P Ͻ 0.05) (22) .
Discussion
In this study, we took advantage of the natural occurrence of genetic change (plasmid loss) in combination with the recently available genome sequence data to determine the association between individual plasmids and infectivity. Examination of Bb B31 clones isolated after 5 in vitro passages revealed that only 3 of 19 clones exhibited a full complement of the 21 plasmids examined. The PCR and Southern blot data indicated that plasmid lp25 is required for infectivity in mice. lp28-1 was also associated with infectivity; the two clones that lacked lp28-1 but contained lp25 expressed an intermediate-infectivity phenotype. Plasmids cp9, cp32-3, lp21, lp28-2, lp28-4, and lp56 were absent in high-infectivity clones; they are therefore not required for infectivity in this model system. Plasmids cp26, cp32-1, cp32-2 and͞or cp32-7, cp32-4, cp32-6, cp32-8, cp32-9, lp17, lp28-3, lp36, lp38, and lp54 were present in all 19 clones, so it is not known whether they are essential for infectivity.
The Bb B31 clones analyzed in this study exhibited high-, intermediate-, and low-infectivity phenotypes ( Table 1 ). The intermediate phenotype was not recognized in previous studies (23) because of the small number of mice used. In the intermediate-infectivity clones 5A2 and 5A8, tissue samples were primarily culture negative except for tibiotarsal joints, which were predominantly culture positive. Needle inoculation of mice was used in this analysis; it is possible that plasmid-content variants could exhibit different phenotypes (both in terms of survival in ticks and infection of the mammalian host) during tick transmission to mice and other animals.
Palmer et al. (4) recently used the Bb B31 genome sequence information to demonstrate the distribution of homologous plasmid sequences in different borrelial isolates by using hybridization with plasmid-specific probes. Our study utilized the genome sequence to analyze the relationship between infectivity and plasmid content. BLASTN searches of entire plasmids against the Bb B31 sequence database were performed to identify unique regions and to design PCR primers specific for each plasmid (see supplemental data). However, one PCR-negative result does not show definitively that a clone lacks a particular plasmid; an alternative possibility is that the plasmid is still present, but that recombination has either deleted or modified the targeted region. Conversely, a plasmid could be truncated or otherwise modified while still preserving the region amplified by using a particular set of PCR primers. The amplicons were not sequenced, so base substitutions could also be present either within or outside the amplified regions.
To determine the validity of our initial PCR results, the presence or absence of the plasmids lp25 and lp28-1 was determined by using a second distant PCR site. In addition, Southern blot analysis was performed by using the primary and secondary amplicons as probes (Fig. 2) . There was an exact correspondence between the initial PCR findings, the PCR results by using a second amplification site, and the Southern blot hybridizations by using either the primary or secondary site amplicons. In addition, the band migration of lp25 and lp28-1 as detected by hybridization did not vary among the clones containing these plasmids, indicating the lack of detectable recombination in the regions outside the amplified segments. Taken together, these results indicate that PCR was a reliable indicator of plasmid presence or loss in this study. Definitive identification of plasmids or genes required for infectivity will require additional studies, including recovery of full infectivity on complementation with the candidate plasmids or genes.
The results strongly suggest that lp25 is associated with infectivity in mice and provide independent confirmation of the previous findings of Xu et al. (12) . In their studies, contourclamped homogeneous electric field PFGE and two-dimensional agarose gel electrophoresis followed by ethidium bromide staining were used to determine plasmid profiles of infectious lowpassage Bb B31 clones. Their Bb B31 clone C-2 lacked only a 27.5-kb linear plasmid; no change in the ID 50 in hamsters was observed. Clone C-9 lacked both the 27.5 linear plasmid and a 9.0-kb circular plasmid; there was a moderate increase in ID 50 lp25 contains 31 predicted ORFs, many of which are either small (Ͻ200 bp) or closely related to paralogous sequences in other plasmids. BBE22 lacks paralogs in Bb but has sequence similarity to genes encoding nicotinamidases and pyrazinamidases, including pncA, which confers pyrazinamide resistance in Mycobacterium tuberculosis (24) . Its function in Bb is currently unknown. The putative gene product of BBE31 is similar to the differentially expressed protein p35 (25, 26) and has a strong signal peptidase I recognition site, suggesting that it is a lipoprotein. The predicted BBE09 gene product is similar to previously identified Bb strain 297 protein p23 (GenBank accession no. AAA22961). BBE18, BBE19, BBE20, and BBE21 correspond to highly conserved paralogous plasmid gene families 49, 32, 50, and 57, respectively, and are putative replication and partition genes (3) . The large predicted product of BBE02 (1,277 amino acids) has extensive protein homology with BBH09 of lp28-3; portions also share homology with multiple genes on lp36. The predicted genes of lp25 need to be examined more thoroughly to determine which are transcriptionally and translationally active and encode possible virulence factors.
Plasmid lp28-1 is associated with reduced infectivity; every Bb B31 clone that lacked lp28-1 was either low or intermediate in infectivity. The two intermediate-infectivity clones that lacked lp28-1 but contained lp25 could be isolated from the tibiotarsal joints of most mice but only rarely from other sites. The joints may represent a preferred site for colonization and survival, where the relatively small numbers of the surviving attenuated borrelia can be detected. Alternatively, lack of lp28-1 may reduce the ability of Bb to colonize organs other than the joints. lp28-1 contains the vmp-like sequence (vls) locus; in this system, antigenic variation results from gene conversion events whereby segments of 15 silent cassettes recombine into the central cassette region of the expressed vlsE gene (13, 27, 28) . The decreased infectivity observed with the absence of lp28-1 may be related to the loss of the vls system, although other genes present on the plasmid could account for this effect. Xu and Johnson (11) noted that the loss of a 27.5-kb linear plasmid from clones C-2 and C-8 of B31 was associated with decreased dissemination of the borreliae in hamsters. They also found that the plasmid appeared to be easily lost. In our study, lp28-1 was absent in 6 of the 19 clones (Fig. 1, Table 2 ). There is currently insufficient information to determine whether the 27.5-kb linear plasmid described by Xu and Johnson is the same as lp28-1.
Plasmid-localized genes encoding virulence factors have been identified in several bacterial pathogens. These include toxin genes (29-37), capsule synthesis operons (38-43), adhesins (44) (45) (46) (47) (48) (49) (50) (51) , and invasion factors (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) . Pathogenesis of Bb in humans is poorly understood. Several genes potentially important during host adaptation, dissemination, infection, and persistence of Bb are plasmid localized. As Bb enters the mammalian host, expression of the temperature-regulated cp26-localized outer surface protein C gene (ospC) increases (64) . Bb binds plasminogen and plasminogen-activator urokinase via OspA, which generates bioactive plasmin at the spirochetal surface, which in turn may aid in degradation of extracellular matrix components and dissemination (50, 51, 54, (65) (66) (67) (68) . However, expression of OspA is down-regulated during the process of tick feeding and Bb transmission (64, 69) . Because purine levels in mammalian blood are low, two cp26-localized purine biosynthesis genes, guaB and guaA, could enable Bb to adapt to the mammalian environment (70) . As Bb migrate to the connective tissues, gene products of lp54-localized dbpA and dbpB may confer binding to decorin and mediate the adherence of Bb to collagen fibers in skin and other tissues (46, 71) . Persistent treatment-resistant Lyme arthritis may be related to host immune reactivity to OspA (72) . Chronic infection and immune evasion may involve VlsE, a surface-localized lipoprotein that undergoes antigenic variation (13, 23, 28 ). An increased understanding of the above putative virulence factors and identification of additional virulence-associated genes are necessary to elucidate the mechanisms of pathogenesis of Lyme disease borrelia.
Identifying infectivity-associated plasmids is a first step toward identifying new virulence factors in Bb and understanding the molecular basis of pathogenicity of this organism. The availability of sequence information of the complete genome (2, 3) and recent improvements in the methods for genetic manipulation (73, 74) should facilitate the characterization of potential virulence factors and their contribution to the disease process.
Note Added in Proof. M. Labandeira-Rey and J. T. Skare (75) have also demonstrated a correlation between decreased infectivity and loss of lp25 and lp28-1, whereas a study by R. T. Marconi (personal communication) indicates that genetic changes other than plasmid loss may contribute to loss of infectivity.
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